IRWD Q4 2017 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

Q4 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$94M+7.7% YoY

Gross Profit

$85M90.3% margin

Operating Income

$23M24.2% margin

Net Income

$12M12.8% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+8.5%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$10M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$606M

Total Liabilities

$596M

Stockholders' Equity

$10M

Cash & Equivalents

$126M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$94M	$87M	+7.7%
Gross Profit	$85M	$86M	-0.6%
Operating Income	$23M	-$6M	+461.3%
Net Income	$12M	-$14M	+189.5%